Recent Press Releases

Alder BioPharmaceuticals (ALDR) Regains Clazakizumab Rights from Bristol-Myers (BMY)

Alder BioPharmaceuticals (NASDAQ: ALDR) announced that it has regained the worldwide rights to clazakizumab, a humanized monoclonal antibody to the pro-inflammatory cytokine IL-6, from Bristol-Myers...

ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID™ (Pimavanserin) for Parkinson's Disease Psychosis

FDA Decision Highlights Significant Unmet Need in the Treatment of Parkinson's Disease Psychosis SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused...

Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer

Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer Conference Call on Tuesday, September 2, 2014 at 8:30...

Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014 - Alirocumab, an investigational treatment for hypercholesterolemia,...

Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial

Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial Study showed significantly more HF-REF patients on LCZ696 regimen...

InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®

PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc.

HeartFlow Fills Four Key Executive Spots

HeartFlow Announces Appointment of Several Key Executive Hires Broad experience, track records of success position company for global growth, commercialization. REDWOOD CITY, Calif.--(BUSINESS...

Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer

NEW YORK and MELBOURNE, Australia, Aug. 24, 2014 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the appointment of pharmaceutical executive Mr Paul Hodgkinson as...

Compugen Ltd. (CGEN) Appoints Mr. Ari Krashin As Chief Financial Officer

TEL AVIV, Israel--(BUSINESS WIRE)-- Compugen Ltd. (NASDAQ: CGEN), a leading drug discovery company focused on therapeutic proteins and monoclonal antibodies in the fields of immunology and oncology,...

Heron Therapeutics Appoints Esmé C. Smith as Vice President, General Counsel and Secretary

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ:HRTX), a specialty pharmaceutical company, today announced that Esmé C. Smith will join the Company as Vice President,...

NC COIN Promotes Karen Shank To Business Development Director

RESEARCH TRIANGLE PARK, N.C. -- NC COIN (North Carolina Center of Innovation for Nanobiotechnology) is pleased to announce the promotion of Karen Shank to Business Development Director. Shank will...

LanzaTech Announces Appointment Of Chief Financial Officer

CHICAGO, IL--(Marketwired - August 25, 2014) - LanzaTech, the revolutionary carbon recycling company, announced the appointment of Gregg Clevenger as Chief Financial Officer. In his role, Clevenger...

Bench International Inc. Appoints Dr. Sally Barennes As Vice President, Executive Recruitment

LOS ANGELES and BASEL – Bench International, a global, milestone-based, performance-driven executive recruiting and consulting firm serving the life sciences industry, has appointed Dr Sally...

David Borasky Has Been Appointed Vice President Of Quality Management For The Copernicus Group IRB

PRINCETON, N.J., Aug. 26, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that it...

ThromboGenics Business Update H1 2014

Financial • Revenues of €7.1 million in the first half of 2014, compared with €102.7 million in the same period in 2013 (including €90 million in milestone payments) • Gross...

Tocagen Inc. Expands Clinical Development Team

SAN DIEGO, Aug. 26, 2014 /PRNewswire/ -- Tocagen Inc. today announced Wayne Saville, M.D., has been named vice president, clinical development, and Mary Rose Keller has been named vice president,...

Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions

Aubagne, France, August 26, 2014 / B3C newswire / – Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, today announced the appointment of Miriam Monge as...

Lycera Appoints Harinder Singh, Ph.D., As Chair Of Scientific Advisory Board

ANN ARBOR, Mich., Aug. 26, 2014 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company pioneering the development of breakthrough oral medicines to treat autoimmune disease and cancer based on the...

Mary Kay Deck Joins Intelomed As Vice President Of Clinical Affairs

PITTSBURGH, Aug. 26, 2014 /PRNewswire/ -- Intelomed is pleased to announce that Mary Kay Deck (Kay) has joined the team as the Vice President of Clinical Affairs. With over 30 years in clinical,...